BrightSpring Health Services (NASDAQ:BTSG) Issues Earnings Results, Beats Expectations By $0.07 EPS

BrightSpring Health Services (NASDAQ:BTSG) released its quarterly earnings results on Friday. The company reported $0.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.07, Briefing.com reports. BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. The firm had revenue of $3.61 billion for the quarter, compared to analysts’ expectations of $3.39 billion. During the same quarter last year, the company earned $0.14 EPS. The firm’s revenue for the quarter was up 25.6% compared to the same quarter last year.

Here are the key takeaways from BrightSpring Health Services’ conference call:

• Q1 financials — Total revenue was $3.6 billion (+26% YoY) with adjusted EBITDA of $190 million (+45% YoY) and a 5.3% adjusted EBITDA margin (up ~70 bps); operating cash flow was $123 million.
• Pharmacy solutions momentum — Specialty & infusion revenue was $2.6 billion (+36% YoY) with ~30% specialty script growth, four new exclusive/ultra-narrow LDDs added (total 153 LDDs), double‑digit infusion growth and new concierge programs like IG Connect.
• Provider services growth & quality — Provider revenue of $442 million (+28% YoY) included home health at $266 million (+49%), with acquired branches contributing ~$79 million of revenue and ~$9 million of adjusted EBITDA in Q1; quality metrics (91% of branches 4+ stars, >99% timely initiation) remain strong.
• Regulatory and conversion headwinds — Home & community pharmacy revenue declined 9% in Q1; management expects ~ $175M full‑year IRA impact to that business and previously cited roughly $181M (IRA specialty) plus ~$250M of brand‑to‑generic pressure (~$600M total headwind), with a $15M EBITDA mitigation unchanged.
• Balance sheet & guidance — Sold community living for ~$811M (pre‑tax) to strengthen the balance sheet, reducing leverage to 2.27x (pro forma 2.40x); 2026 guidance (ex‑community living) targets $14.725B–$15.225B revenue and $795M–$825M adjusted EBITDA, which includes ~ $30M expected contribution from acquired Amedisys/LHC assets.

BrightSpring Health Services Price Performance

BTSG stock traded up $4.61 during midday trading on Friday, reaching $52.58. The stock had a trading volume of 9,470,421 shares, compared to its average volume of 2,014,496. The company’s fifty day simple moving average is $43.50 and its 200 day simple moving average is $38.72. The company has a current ratio of 1.57, a quick ratio of 1.12 and a debt-to-equity ratio of 1.32. The company has a market cap of $10.16 billion, a price-to-earnings ratio of 46.12, a price-to-earnings-growth ratio of 0.68 and a beta of 1.72. BrightSpring Health Services has a 52-week low of $19.01 and a 52-week high of $54.68.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on BTSG shares. Mizuho lifted their price target on shares of BrightSpring Health Services from $50.00 to $52.00 and gave the company an “outperform” rating in a research note on Wednesday, March 18th. Morgan Stanley lifted their price target on shares of BrightSpring Health Services from $40.00 to $48.00 and gave the company an “overweight” rating in a research note on Wednesday, March 4th. UBS Group lifted their price target on shares of BrightSpring Health Services from $53.00 to $55.00 and gave the company a “buy” rating in a research note on Wednesday, March 18th. BTIG Research reissued a “buy” rating and issued a $55.00 price target on shares of BrightSpring Health Services in a research note on Thursday, March 19th. Finally, Wells Fargo & Company raised their price objective on BrightSpring Health Services from $43.00 to $50.00 and gave the company an “overweight” rating in a report on Monday, March 2nd. Two research analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average price target of $46.50.

Insider Buying and Selling at BrightSpring Health Services

In other BrightSpring Health Services news, CFO Jennifer A. Phipps sold 35,000 shares of the firm’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $41.15, for a total value of $1,440,250.00. Following the transaction, the chief financial officer owned 196,840 shares in the company, valued at approximately $8,099,966. This trade represents a 15.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Lisa A. Nalley sold 30,000 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total value of $1,234,500.00. Following the completion of the transaction, the insider owned 110,594 shares in the company, valued at $4,550,943.10. The trade was a 21.34% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 285,000 shares of company stock worth $11,727,750. Corporate insiders own 2.80% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of BTSG. The Manufacturers Life Insurance Company raised its holdings in shares of BrightSpring Health Services by 936.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 2,276,583 shares of the company’s stock worth $53,705,000 after acquiring an additional 2,056,920 shares during the period. State Street Corp raised its holdings in shares of BrightSpring Health Services by 99.5% during the 4th quarter. State Street Corp now owns 4,033,149 shares of the company’s stock worth $151,041,000 after acquiring an additional 2,011,095 shares during the period. Jane Street Group LLC raised its holdings in shares of BrightSpring Health Services by 855.4% during the 2nd quarter. Jane Street Group LLC now owns 2,076,730 shares of the company’s stock worth $48,990,000 after acquiring an additional 1,859,369 shares during the period. Invesco Ltd. raised its holdings in shares of BrightSpring Health Services by 13.4% during the 4th quarter. Invesco Ltd. now owns 10,595,232 shares of the company’s stock worth $396,791,000 after acquiring an additional 1,248,107 shares during the period. Finally, Braidwell LP purchased a new position in shares of BrightSpring Health Services during the 4th quarter worth $44,782,000.

More BrightSpring Health Services News

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Q1 results beat street estimates — EPS of $0.39 topped consensus (~$0.32) and revenue of $3.61B beat estimates (~$3.39B); revenue was up ~25.6% year‑over‑year, signaling healthy top‑line growth. Quarterly results and call
• Positive Sentiment: Company raised full‑year 2026 revenue and adjusted EBITDA guidance (management increased its FY revenue range to roughly $14.7B–$15.2B), which supports the rally and suggests management confidence in demand and margins. BrightSpring extends rally with upgraded forecast
• Positive Sentiment: Street recognition — BTSG was added to Zacks’ top growth (Rank #1) list, which can support additional retail/institutional interest. Zacks Rank #1 inclusion
• Neutral Sentiment: Investor materials available — management hosted a call and posted a press release and slide deck with more detail on results and guidance for investors to evaluate execution and forward assumptions. Press release and slides
• Negative Sentiment: Valuation and leverage remain considerations — BTSG trades at a high P/E (~60) with a beta >2 and debt/equity ~1.32; strong results improve the story but raise expectations that the company must sustain growth to justify the valuation.

BrightSpring Health Services Company Profile

BrightSpring Health Services (NASDAQ: BTSG) is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company’s operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient’s home environment, fostering independence and improving quality of life.